NP
NASDAQ · NPCE
NeuroPace, Inc.
Healthcare · Medical - Devices
$14.10
Down-$0.07 (-0.50%)
Updated Sep 17, 2026, 2:09 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 548.85M
- P/E ratio
- -26.65
- Dividend yield
- 0.00%
- 52-week range
- $9.22 – $19.60
- Volume
- 116.14K
- Avg. volume
- 204.94K
Price performance
NPCE price history
1M range · 20 trading sessions · Daily adjusted prices
NPCE closed at $14.10 after 20 trading sessions, down 3.69% for the selected period.
- Last close
- $14.10
- Period change
- -3.69%
- Period low
- $13.87
- Period high
- $15.19
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $14.28 | $14.57 | $14.04 | $14.10 | 116.14K |
| Sep 15, 2026 | $14.48 | $14.49 | $14.0506 | $14.25 | 96.84K |
| Sep 14, 2026 | $14.01 | $14.655 | $13.95 | $14.59 | 125.89K |
| Sep 11, 2026 | $14.04 | $14.13 | $13.815 | $14.04 | 107.48K |
| Sep 10, 2026 | $14.46 | $14.465 | $13.825 | $13.87 | 73.03K |
| Sep 9, 2026 | $14.68 | $14.77 | $14.41 | $14.50 | 78.58K |
| Sep 8, 2026 | $14.65 | $15.10 | $14.54 | $14.76 | 105.2K |
| Sep 4, 2026 | $14.62 | $14.90 | $14.47 | $14.90 | 92.32K |
| Sep 3, 2026 | $15.25 | $15.48 | $14.49 | $14.75 | 141.5K |
| Sep 2, 2026 | $14.75 | $15.555 | $14.68 | $15.19 | 163.71K |
| Sep 1, 2026 | $14.70 | $14.86 | $14.515 | $14.74 | 132.83K |
| Aug 31, 2026 | $14.41 | $14.67 | $14.24 | $14.65 | 148.26K |
| Aug 28, 2026 | $14.09 | $14.55 | $13.7643 | $14.41 | 129.42K |
| Aug 27, 2026 | $14.60 | $14.81 | $14.07 | $14.13 | 148.09K |
| Aug 26, 2026 | $14.23 | $14.86 | $14.10 | $14.68 | 172.84K |
| Aug 25, 2026 | $14.04 | $14.27 | $13.9723 | $14.16 | 153.4K |
| Aug 24, 2026 | $14.10 | $14.4799 | $13.96 | $13.99 | 117.66K |
| Aug 21, 2026 | $14.14 | $14.22 | $13.87 | $14.03 | 115.98K |
| Aug 20, 2026 | $14.35 | $14.60 | $13.56 | $14.02 | 191.8K |
| Aug 19, 2026 | $14.45 | $15.28 | $14.45 | $14.64 | 106.61K |
Latest NPCE news
The latest Smart Investors Daily articles mentioning NPCE.
Stock researchResearch & News · News
Loading stock research…

